These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 8174120

  • 1. Intrathecal gene therapy for malignant leptomeningeal neoplasia.
    Ram Z, Walbridge S, Oshiro EM, Viola JJ, Chiang Y, Mueller SN, Blaese RM, Oldfield EH.
    Cancer Res; 1994 Apr 15; 54(8):2141-5. PubMed ID: 8174120
    [Abstract] [Full Text] [Related]

  • 2. Toxicity studies and distribution dynamics of retroviral vectors following intrathecal administration of retroviral vector-producer cells.
    Oshiro EM, Viola JJ, Oldfield EH, Walbridge S, Bacher J, Frank JA, Blaese RM, Ram Z.
    Cancer Gene Ther; 1995 Jun 15; 2(2):87-95. PubMed ID: 7621261
    [Abstract] [Full Text] [Related]

  • 3. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH.
    Cancer Res; 1993 Jan 01; 53(1):83-8. PubMed ID: 8380127
    [Abstract] [Full Text] [Related]

  • 4. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo.
    Lyons RM, Forry-Schaudies S, Otto E, Wey C, Patil-Koota V, Kaloss M, McGarrity GJ, Chiang YL.
    Cancer Gene Ther; 1995 Dec 01; 2(4):273-80. PubMed ID: 8548581
    [Abstract] [Full Text] [Related]

  • 5. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar 01; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 6. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene.
    Boviatsis EJ, Park JS, Sena-Esteves M, Kramm CM, Chase M, Efird JT, Wei MX, Breakefield XO, Chiocca EA.
    Cancer Res; 1994 Nov 15; 54(22):5745-51. PubMed ID: 7954393
    [Abstract] [Full Text] [Related]

  • 7. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
    Esandi MC, van Someren GD, Vincent AJ, van Bekkum DW, Valerio D, Bout A, Noteboom JL.
    Gene Ther; 1997 Apr 15; 4(4):280-7. PubMed ID: 9176512
    [Abstract] [Full Text] [Related]

  • 8. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
    Berenstein M, Adris S, Ledda F, Wolfmann C, Medina J, Bravo A, Mordoh J, Chernajovsky Y, Podhajcer OL.
    Cancer Gene Ther; 1999 Apr 15; 6(4):358-66. PubMed ID: 10419054
    [Abstract] [Full Text] [Related]

  • 9. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors.
    Ram Z, Culver KW, Walbridge S, Frank JA, Blaese RM, Oldfield EH.
    J Neurosurg; 1993 Sep 15; 79(3):400-7. PubMed ID: 8395592
    [Abstract] [Full Text] [Related]

  • 10. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR, Chiocca A, Breakefield XO.
    Cancer Gene Ther; 1996 Sep 15; 3(2):99-106. PubMed ID: 8729908
    [Abstract] [Full Text] [Related]

  • 11. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
    Bilbao R, Gérolami R, Bralet MP, Qian C, Tran PL, Tennant B, Prieto J, Bréchot C.
    Cancer Gene Ther; 2000 May 15; 7(5):657-62. PubMed ID: 10830712
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K, Sandmair AM, Turunen M, Vanninen R, Vainio P, Kauppinen R, Johansson R, Vapalahti M, Ylä-Herttuala S.
    Cancer Gene Ther; 2002 Nov 15; 9(11):917-24. PubMed ID: 12386830
    [Abstract] [Full Text] [Related]

  • 13. Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging.
    Maron A, Gustin T, Le Roux A, Mottet I, Dedieu JF, Brion JP, Demeure R, Perricaudet M, Octave JN.
    Gene Ther; 1996 Apr 15; 3(4):315-22. PubMed ID: 8732163
    [Abstract] [Full Text] [Related]

  • 14. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
    Tjuvajev JG, Chen SH, Joshi A, Joshi R, Guo ZS, Balatoni J, Ballon D, Koutcher J, Finn R, Woo SL, Blasberg RG.
    Cancer Res; 1999 Oct 15; 59(20):5186-93. PubMed ID: 10537296
    [Abstract] [Full Text] [Related]

  • 15. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy.
    Izquierdo M, Martín V, de Felipe P, Izquierdo JM, Pérez-Higueras A, Cortés ML, Paz JF, Isla A, Blázquez MG.
    Gene Ther; 1996 Jun 15; 3(6):491-5. PubMed ID: 8789798
    [Abstract] [Full Text] [Related]

  • 16. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
    Miura F, Moriuchi S, Maeda M, Sano A, Maruno M, Tsanaclis AM, Marino R, Glorioso JC, Yoshimine T.
    Gene Ther; 2002 Dec 15; 9(24):1653-8. PubMed ID: 12457278
    [Abstract] [Full Text] [Related]

  • 17. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 18. [Gene therapy of a model of glioblastoma in rats using adenovirus vector encoding the HSVtk gene].
    Quillien V, Heresbach Le Berre N, Dufour T, Denais A, Guegan Y, Ferry N, Bloin V.
    Bull Cancer; 1997 Nov 15; 84(11):1047-52. PubMed ID: 9536986
    [Abstract] [Full Text] [Related]

  • 19. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M, Kouri CE, Force S, Chang M, Amin K, Xu K, Blair I, Kaiser L, Albelda S.
    Gene Ther; 1999 Sep 15; 6(9):1600-10. PubMed ID: 10490770
    [Abstract] [Full Text] [Related]

  • 20. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD, Boenicke L, Schniewind B, Henne-Bruns D, Kalthoff H.
    Cancer Gene Ther; 2000 Jun 15; 7(6):927-38. PubMed ID: 10880025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.